Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction

被引:143
作者
Baber, Syed R. [1 ]
Deng, Weiwen [1 ]
Master, Ryan G. [1 ]
Bunnell, Bruce A. [1 ]
Taylor, Bradley K. [1 ]
Murthy, Subramanyam N. [1 ]
Hyman, Albert L. [1 ]
Kadowitz, Philip J. [1 ]
机构
[1] Tulane Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2007年 / 292卷 / 02期
关键词
marrow stromal cells;
D O I
10.1152/ajpheart.00173.2006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The administration of mesenchymal stem cells (MSCs) has been proposed for the treatment of pulmonary hypertension. However, the effect of intratracheally administered MSCs on the pulmonary vascular bed in monocrotaline-treated rats has not been determined. In the present study, the effect of intratracheal administration of rat MSCs (rMSCs) on monocrotaline-induced pulmonary hypertension and impaired endothelium-dependent responses were investigated in the rat. Intravenous injection of monocrotaline increased pulmonary arterial pressure and vascular resistance and decreased pulmonary vascular responses to acetylcholine without altering responses to sodium nitroprusside and without altering systemic responses to the vasodilator agents when responses were evaluated at 5 wk. The intratracheal injection of 3 x 10(6) rMSCs 2 wk after administration of monocrotaline attenuated the rise in pulmonary arterial pressure and pulmonary vascular resistance and restored pulmonary responses to acetylcholine toward values measured in control rats. Treatment with rMSCs decreased the right ventricular hypertrophy induced by monocrotaline. Immunohistochemical studies showed widespread distribution of lacZ-labeled rMSCs in lung parenchyma surrounding airways in monocrotaline-treated rats. Immunofluorescence studies revealed that transplanted rMSCs retained expression of von Willebrand factor and smooth muscle actin markers specific for endothelial and smooth muscle phenotypes. However, immunolabeled cells were not detected in the wall of pulmonary vessels. These data suggest that the decrease in pulmonary vascular resistance and improvement in response to acetylcholine an endothelium-dependent vasodilator in monocrotaline-treated rats may result from a paracrine effect of the transplanted rMSCs in lung parenchyma, which improves vascular endothelial function in the monocrotaline-injured lung.
引用
收藏
页码:H1120 / H1128
页数:9
相关论文
共 41 条
[31]   Adrenomedullin in the treatment of pulmonary hypertension [J].
Nagaya, N ;
Kangawa, K .
PEPTIDES, 2004, 25 (11) :2013-2018
[32]   Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells [J].
Nagaya, N ;
Kangawa, K ;
Kanda, M ;
Uematsu, M ;
Horio, T ;
Fukuyama, N ;
Hino, J ;
Harada-Shiba, M ;
Okumura, H ;
Tabata, Y ;
Mochizuki, N ;
Chiba, Y ;
Nishioka, K ;
Miyatake, K ;
Asahara, T ;
Hara, H ;
Mori, H .
CIRCULATION, 2003, 108 (07) :889-895
[33]   Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects [J].
Ortiz, LA ;
Gambelli, F ;
McBride, C ;
Gaupp, D ;
Baddoo, M ;
Kaminski, N ;
Phinney, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8407-8411
[34]   In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction chronically hypoxic rats [J].
Pozeg, ZI ;
Michelakis, ED ;
McMurtry, MS ;
Thébaud, B ;
Wu, XC ;
Dyck, JRB ;
Hashimoto, K ;
Wang, SH ;
Harry, G ;
Sultanian, R ;
Koshal, A ;
Archer, SL .
CIRCULATION, 2003, 107 (15) :2037-2044
[35]   Endothelin, receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension [J].
Prié, S ;
Stewart, DJ ;
Dupuis, J .
CIRCULATION, 1998, 97 (21) :2169-2174
[36]   Marrow stromal cells as steam cells for nonhematopoietic tissues [J].
Prockop, DJ .
SCIENCE, 1997, 276 (5309) :71-74
[37]   PRIMARY PULMONARY-HYPERTENSION - A NATIONAL PROSPECTIVE-STUDY [J].
RICH, S ;
DANTZKER, DR ;
AYRES, SM ;
BERGOFSKY, EH ;
BRUNDAGE, BH ;
DETRE, KM ;
FISHMAN, AP ;
GOLDRING, RM ;
GROVES, BM ;
KOERNER, SK ;
LEVY, PC ;
REID, LM ;
VREIM, CE ;
WILLIAMS, GW .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (02) :216-223
[38]   Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs [J].
Takahashi, M ;
Nakamura, T ;
Toba, T ;
Kajiwara, N ;
Kato, H ;
Shimizu, Y .
TISSUE ENGINEERING, 2004, 10 (5-6) :771-779
[39]   Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion [J].
Terada, N ;
Hamazaki, T ;
Oka, M ;
Hoki, M ;
Mastalerz, DM ;
Nakano, Y ;
Meyer, EM ;
Morel, L ;
Petersen, BE ;
Scott, EW .
NATURE, 2002, 416 (6880) :542-545
[40]   Changing potency by spontaneous fusion [J].
Ying, QL ;
Nichols, J ;
Evans, EP ;
Smith, AG .
NATURE, 2002, 416 (6880) :545-548